RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

Rhea-AI Summary

RxSight, Inc. (NASDAQ: RXST), a company specializing in ophthalmic medical devices for post-cataract surgery vision customization, has announced its participation in the upcoming Stifel Virtual Ophthalmology Forum. The company's management team will engage in a fireside chat on Tuesday, May 27, 2025, at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. Interested parties can access both the live and archived versions of the presentation through RxSight's investor relations website at investors.rxsight.com.

News Market Reaction

-3.67%

1 alert

-3.67% News Effect

On the day this news was published, RXST declined 3.67%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Stifel Virtual Ophthalmology Forum.

RxSight’s management is scheduled to participate in a fireside chat on Tuesday, May 27, 2025, at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. A live and archived webcast of the presentation will be available on the Company’s investor relations website at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

FAQ

When is RxSight (RXST) presenting at the Stifel Virtual Ophthalmology Forum 2025?

RxSight will participate in a fireside chat on Tuesday, May 27, 2025, at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time.

Where can I watch RxSight's (RXST) presentation at the Stifel Ophthalmology Forum?

The presentation can be accessed through a live and archived webcast on RxSight's investor relations website at investors.rxsight.com.

What does RxSight (RXST) specialize in?

RxSight is an ophthalmic medical device company that specializes in providing high-quality customized vision to patients following cataract surgery.

What type of event is RxSight (RXST) participating in for May 2025?

RxSight is participating in the Stifel Virtual Ophthalmology Forum, where management will conduct a fireside chat presentation.